(Information sent by the signatory company)
RRD Biopharma Development is the new dynamic brand of RRD International. Launched to reflect the company's unique approach to drug development through its successful Product Development Team model.
ROCKVILLE, Md., Feb. 28, 2024 /PRNewswire/ -- RRD International today announced that it has launched its new brand RRD Biopharma Development, reflecting its unique offering of providing strategy-based product development services to biopharmaceutical companies and investors.
The rebrand includes a new updated website showcasing its innovative product development team (PDT) model. The PDT model enables biopharmaceutical companies with limited infrastructure to address drug development challenges efficiently and effectively, resulting in more predictable product development outcomes.
RRD's high-caliber, fast-starting team partners with companies around the world who apply their exceptional expertise to accelerate drug development and reduce risk. By investing in the success of the asset, they improve value and drive benefits for patients.
The company, founded in 2002, is part of Uniphar Group, an international diversified healthcare services company based in Dublin, Ireland. RRD's asset-focused development approach has helped create >$3 billion in value for its partners over the past 21 years.
Commenting on the rebrand, Scott Tarrant, CEO of RRD Biopharma Development, said: "Our unique approach uses insights and expertise to strategize, optimize and execute biopharmaceutical development, maximizing asset value and accelerating access to patients to new medications.
"Our dynamic new brand more accurately reflects and places emphasis on our development offering and the value we deliver every day to our partners.
"The enhanced brand better communicates who we are and what we do, ultimately supporting our growth and making us a recognized development partner in the market," concluded Tarrant.
About RRD Biopharma Development
RRD Biopharma Development is a product development company that provides integrated, expert-level strategic, regulatory and operational support to biopharmaceutical companies and investors. The company's unique Product Development Team (PDT) model provides an effective, asset-focused alternative to traditional industry practices. While comprehensive in value, structure and function (encompassing all aspects of a development program), the PDT model is also highly resource efficient and intensely focused on minimizing cost, time and risk to achieve significant value inflections. , whether through human proof of concept (hPOC) or through marketing approval. Since 2002, RRD has worked with over 200 organizations across all major classes and therapeutic areas. For more information, visit rrdbiodev.com.
Logo - https://mma.prnewswire.com/media/2346255...
View original content: https://www.prnewswire.com/news-releases/rrd-international-es-ahora-rrd-biopharma-development-302070167.html
